Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer
Meiying Zhang(Fujian Medical University), Mingzhou Guo(Chinese PLA General Hospital), Aiai Gao(Chinese PLA General Hospital), Qian Wang(Xi'an Honghui Hospital), Fangfang Shen(Shanxi Medical University), Xiaoyun Li(Integrated Chinese Medicine (China)), Kunlun He(Chinese PLA General Hospital), Yuanxin Yao(Chinese PLA General Hospital), James G. Herman(UPMC Hillman Cancer Center)
Cited by 4
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
Correlation of O<sup>6</sup>-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
|Journal of Clinical Oncology|2008|805